Finch Therapeutics Group (FNCH) Short Interest Ratio & Short Volume $12.50 -0.25 (-1.96%) As of 02:54 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Finch Therapeutics Group Short Interest DataFinch Therapeutics Group (FNCH) has a short interest of 100 shares, representing 0.01% of the float (the number of shares available for trading by the public). This marks a -88.89% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 2,120 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest900 sharesChange Vs. Previous Month-88.89%Dollar Volume Sold Short$1.32 thousandShort Interest Ratio0.0 Days to CoverLast Record DateJune 30, 2025Outstanding Shares1,606,000 sharesShort Percent of Float0.01%Today's Trading Volume500 sharesAverage Trading Volume2,120 sharesToday's Volume Vs. Average24% Short Selling Finch Therapeutics Group? Sign up to receive the latest short interest report for Finch Therapeutics Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFNCH Short Interest Over TimeFNCH Days to Cover Over TimeFNCH Percentage of Float Shorted Over Time Finch Therapeutics Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025100 shares $1.32 thousand -88.9%0.0%0 $13.20 6/15/2025900 shares $12.38 thousand No Change0.1%0.6 $13.75 5/31/2025900 shares $12.15 thousand +12.5%0.1%0.3 $13.50 5/15/2025800 shares $10.57 thousand -11.1%N/A0.2 $13.21 4/30/2025900 shares $11.25 thousand -18.2%N/A0.1 $12.50 4/15/20251,100 shares $14.63 thousand -31.3%N/A0.3 $13.30 3/14/20251,600 shares $21.84 thousand No ChangeN/A0.3 $13.65 2/28/20251,600 shares $25.26 thousand -36.0%N/A0.4 $15.79 2/14/20252,500 shares $37.50 thousand +66.7%N/A0.3 $15.00 1/31/20251,500 shares $16.88 thousand No ChangeN/A0.8 $11.25 Get the Latest News and Ratings for FNCH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. 1/15/20251,500 shares $16.37 thousand -6.3%N/A0.9 $10.91 5/15/202419,200 shares $40.32 thousand -27.3%2.8%0.3 $2.10 4/30/202426,400 shares $61.78 thousand +149.1%4.9%0.5 $2.34 4/15/202410,600 shares $23.80 thousand +15.2%2.0%0.2 $2.25 3/31/20249,200 shares $23.92 thousand -20.7%1.7%0.5 $2.60 3/15/202411,600 shares $29.64 thousand +383.3%2.2%0.6 $2.56 2/29/20242,400 shares $6.24 thousand -27.3%0.5%0.1 $2.60 2/15/20243,300 shares $8.25 thousand +65.0%0.6%0.1 $2.50 1/31/20242,000 shares $5.50 thousand +300.0%0.4%0.1 $2.75 1/15/2024500 shares $1.56 thousand -73.7%0.1%0 $3.11 12/31/20231,900 shares $6.86 thousand -65.5%0.4%0.1 $3.61 12/15/20235,500 shares $18.92 thousand -61.3%1.0%0.3 $3.44 11/30/202314,200 shares $61.06 thousand -27.9%2.5%1.7 $4.30 11/15/202319,700 shares $79.00 thousand -3.9%3.4%2.8 $4.01 10/31/202320,500 shares $79.54 thousand -11.6%3.6%2.8 $3.88 10/15/202323,200 shares $103.94 thousand -4.1%4.1%2.6 $4.48 9/30/202324,200 shares $125.36 thousand -15.1%4.3%2.5 $5.18 9/15/202328,500 shares $163.59 thousand +27.2%5.1%2.7 $5.74 8/31/202322,400 shares $144.70 thousand +4.7%4.0%0.6 $6.46 8/15/202321,400 shares $133.96 thousand +57.4%3.8%0.6 $6.26 7/31/202313,600 shares $104.18 thousand -20.0%0.1%0.4 $7.66 7/15/202317,000 shares $155.89 thousand -25.4%0.1%0.5 $9.17 6/30/202322,800 shares $194.48 thousand -20.8%4.0%0.6 $8.53 6/15/202328,800 shares $249.12 thousand -73.1%5.1%0.8 $8.65 5/31/2023106,900 shares $897.96 thousand +73.5%0.6%0.4 $8.40 5/15/202361,600 shares $22.27 thousand -73.3%0.4%0.2 $0.36 4/30/2023230,300 shares $92.86 thousand +83.1%1.4%0.8 $0.40 4/15/2023125,800 shares $49.36 thousand +47.0%0.7%0.4 $0.39 3/31/202385,600 shares $33.64 thousand -9.9%0.5%0.5 $0.39 3/15/202395,000 shares $35.15 thousand -51.7%0.6%0.5 $0.37[ATTENTION] This Crypto Rocket Is About Launch… (Ad)Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending.Join The Crypto Code Workshop + get $10 in Bitcoin for attending 2/28/2023196,500 shares $81.35 thousand +10.2%1.2%1.2 $0.41 2/15/2023178,400 shares $75.12 thousand +49.8%1.1%1.1 $0.42 1/31/2023119,100 shares $59.55 thousand -4.4%0.7%0.9 $0.50 1/15/2023124,600 shares $69.78 thousand +22.4%0.8%1.2 $0.56 12/30/2022101,800 shares $48.86 thousand +27.4%0.6%1.4 $0.48 12/15/202279,900 shares $64.71 thousand +6.4%0.5%1.3 $0.81 11/30/202275,100 shares $73.61 thousand -17.7%0.5%1.8 $0.98 11/15/202291,300 shares $98.44 thousand -17.9%0.6%2.1 $1.08 10/31/2022111,200 shares $144.56 thousand -6.1%0.7%2.5 $1.30 10/15/2022118,400 shares $188.26 thousand -21.0%0.7%2.6 $1.59 9/30/2022149,900 shares $250.33 thousand +19.6%1.0%3.2 $1.67 9/15/2022125,300 shares $334.55 thousand -12.7%0.8%2 $2.67 8/31/2022143,600 shares $310.18 thousand -37.9%1.0%2 $2.16 8/15/2022231,400 shares $647.92 thousand -19.6%1.5%2.8 $2.80 7/31/2022287,700 shares $561.02 thousand +0.6%1.9%2.4 $1.95 7/15/2022285,900 shares $651.85 thousand -24.5%1.9%0.3 $2.28 6/30/2022378,600 shares $1.08 million -41.3%2.5%0.4 $2.84 6/15/2022644,700 shares $1.75 million -14.1%4.3%0.7 $2.71 5/31/2022750,800 shares $1.78 million -0.6%5.0%0.8 $2.37 5/15/2022755,200 shares $1.68 million +296.0%5.0%0.8 $2.23 4/30/2022190,700 shares $482.47 thousand +2.3%1.3%0.2 $2.53 4/15/2022186,500 shares $760.92 thousand -13.1%1.2%5.3 $4.08 3/31/2022214,500 shares $1.08 million -9.0%1.4%6.3 $5.03 3/15/2022235,700 shares $1.22 million -6.5%1.6%5.7 $5.17 2/28/2022252,200 shares $2.11 million -0.4%1.7%3.5 $8.37 2/15/2022253,100 shares $2.21 million -0.5%1.7%3 $8.75 1/31/2022254,300 shares $2.16 million +9.9%1.5%2.5 $8.48 1/15/2022231,400 shares $2.11 million -8.9%1.4%2.1 $9.10 12/31/2021253,900 shares $2.53 million +58.1%1.5%2.3 $9.97 12/15/2021160,600 shares $1.52 million -30.5%1.0%1.5 $9.47 11/30/2021231,100 shares $3.84 million +22.5%1.4%2.9 $16.62 11/15/2021188,700 shares $2.74 million +0.4%1.1%3.1 $14.54 10/29/2021187,900 shares $2.52 million -19.1%1.1%4 $13.40 10/15/2021232,200 shares $2.77 million -2.6%1.4%6.8 $11.95 9/30/2021238,300 shares $3.10 million -2.4%1.4%5 $13.00 9/15/2021244,100 shares $3.38 million -16.6%1.5%3.7 $13.83 8/31/2021292,800 shares $4.14 million -31.0%1.8%4 $14.15 8/13/2021424,600 shares $5.58 million No Change2.5%5.7 $13.15 FNCH Short Interest - Frequently Asked Questions What is Finch Therapeutics Group's current short interest? Short interest is the volume of Finch Therapeutics Group shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 100 shares of FNCH short. 0.01% of Finch Therapeutics Group's shares are currently sold short. Learn More on Finch Therapeutics Group's current short interest. What is a good short interest percentage for Finch Therapeutics Group? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of Finch Therapeutics Group's floating shares are currently sold short. Is Finch Therapeutics Group's short interest increasing or decreasing? Finch Therapeutics Group saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 100 shares, a drop of 88.9% from the previous total of 900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Finch Therapeutics Group's short interest compare to its competitors? 0.01% of Finch Therapeutics Group's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Finch Therapeutics Group: Forte Biosciences, Inc. (1.38%), Entera Bio Ltd. (0.14%), TScan Therapeutics, Inc. (4.52%), IGM Biosciences, Inc. (2.36%), Verrica Pharmaceuticals Inc. (0.43%), Cabaletta Bio, Inc. (12.46%), ESSA Pharma Inc. (1.99%), Zura Bio Limited (11.90%), ImmunoPrecise Antibodies Ltd. (0.58%), Quince Therapeutics, Inc. (1.29%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Finch Therapeutics Group stock? Short selling FNCH is an investing strategy that aims to generate trading profit from Finch Therapeutics Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Finch Therapeutics Group? A short squeeze for Finch Therapeutics Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FNCH, which in turn drives the price of the stock up even further. How often is Finch Therapeutics Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FNCH, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies FBRX Short Squeeze ENTX Short Squeeze TCRX Short Squeeze IGMS Short Squeeze VRCA Short Squeeze CABA Short Squeeze EPIX Short Squeeze ZURA Short Squeeze IPA Short Squeeze QNCX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FNCH) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Finch Therapeutics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Finch Therapeutics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FNCH Stock Alerts